Terms: = Lung cancer AND AFF3, MLLT2-like, 3899, ENSG00000144218, LAF4, P51826 AND Prognosis
2 results:
1. The Underlying Mechanism Involved in Gefitinib Resistance and Corresponding Experiment Validation in lung cancer.
Song P; Zhou J; Wu K; Wang W; Gu S
Mediators Inflamm; 2023; 2023():9658912. PubMed ID: 37205010
[TBL] [Abstract] [Full Text] [Related]
2. Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1.
Jutant EM; Jaïs X; Girerd B; Savale L; Ghigna MR; Perros F; Mignard X; Jevnikar M; Bourlier D; Prevot G; Tromeur C; Bauer F; Bergot E; Dauphin C; Favrolt N; Traclet J; Soumagne T; De Groote P; Chabanne C; Magro P; Bertoletti L; Gueffet JP; Chaouat A; Goupil F; Moceri P; Borie R; Fadel E; Wolkenstein P; Brillet PY; Simonneau G; Sitbon O; Humbert M; Montani D
Am J Respir Crit Care Med; 2020 Sep; 202(6):843-852. PubMed ID: 32437637
[No Abstract] [Full Text] [Related]
